Cellular immunotherapy in diffuse large cell B lymphoma: a comparison of allograft and chemical antigen receptor T cells

被引：0
|
作者：
Van-Minh Nguyen
Guidez, Stephanie
机构：
来源：
HEMATOLOGIE | 2021年 / 27卷 / 01期
关键词：
D O I：
10.1684/hma.2021.1623
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [31] Inflammatory Cells in Diffuse Large B Cell Lymphoma
    Tamma, Roberto
    Ranieri, Girolamo
    Ingravallo, Giuseppe
    Annese, Tiziana
    Oranger, Angela
    Gaudio, Francesco
    Musto, Pellegrino
    Specchia, Giorgina
    Ribatti, Domenico
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 17
  • [32] Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T -Cell (CAR -T) Therapy for Diffuse Large B -Cell Lymphoma
    Gupta, Shruti
    Seethapathy, Harish
    Strohbehn, Ian A.
    Frigault, Matthew J.
    O'Donnell, Elizabeth K.
    Jacobson, Caron A.
    Motwani, Shveta S.
    Parikh, Samir M.
    Curhan, Gary C.
    Reynolds, Kerry L.
    Leaf, David E.
    Sise, Meghan E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (01) : 63 - 71
  • [33] Geographic and Racial Disparities in Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials Access for Diffuse Large B-Cell Lymphoma
    Shahzad, Moazzam
    Khalid, Muhammad Fareed
    Amin, Muhammad Kashif
    Basharat, Ahmad
    Ammad-Ud-Din, Mohammad
    Park, Robin
    Anwar, Iqra
    Faisal, Muhammad Salman
    Jaglal, Michael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (05): : 316 - 322
  • [34] Chimeric antigen receptor T-cells might unmask transdifferentiated histiocytic sarcoma during diffuse large B-cell lymphoma treatment
    Gravenmier, Curtis
    Shah, Bijal
    Hussaini, Mohammad
    Zhang, Ling
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 674 - 678
  • [35] Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Combined with Zanubrutinib in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Wang, Langqi
    Yang, Jilong
    Jin, Bo
    Wang, Bo
    Zhou, Lijuan
    Zhuo, Yaqi
    Chen, Huifang
    Chang, Lung-Ji
    Tu, Sanfang
    Li, Yuhua
    BLOOD, 2023, 142
  • [36] Chidamide and sintilimab combination in diffuse large B-cell lymphoma progressing after chimeric antigen receptor T therapy
    Hao, Yuan-Yuan
    Chen, Pan-Pan
    Yuan, Xiang-Gui
    Zhao, Ai-Qi
    Liang, Yun
    Liu, Hui
    Qian, Wen-Bin
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (19) : 6555 - 6562
  • [37] Geographic and Racial Disparities in Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials Access for Diffuse Large B-Cell Lymphoma
    Shahzad, Moazzam
    Khalid, Muhammad Fareed
    Basharat, Ahmad
    Butt, Atif
    Abbas, Sakina
    Zahoor, Hovra
    Mohsin, Fizza
    Anwar, Iqra
    Amin, Muhammad Kashif
    Faisal, Muhammad Salman
    Jaglal, Michael V.
    BLOOD, 2023, 142
  • [38] Chidamide and sintilimab combination in diffuse large B-cell lymphoma progressing after chimeric antigen receptor T therapy
    Yuan-Yuan Hao
    Pan-Pan Chen
    Xiang-Gui Yuan
    Aiqi Zhao
    Yun Liang
    Hui Liu
    Wen-Bin Qian
    World Journal of Clinical Cases, 2022, (19) : 6555 - 6562
  • [39] Chimeric antigen receptor T cells for mature B-cell lymphoma and Burkitt lymphoma
    Hsieh, Emily M.
    Rouce, Rayne H.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2020, (01) : 487 - 493
  • [40] (CAR-)T cell dynamics following chimeric antigen receptor T cells for large B cell lymphoma: a translational tale
    Gambella, M.
    Carlomagno, S.
    Raiola, A. M.
    Sivori, S.
    Angelucci, E.
    LEUKEMIA & LYMPHOMA, 2025,
12345